USA Compression Partners, LP
USA Compression Partners, LP (USAC) Financial Performance & Income Statement Overview
Analyze USA Compression Partners, LP (USAC) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
USA Compression Partners, LP (USAC) Income Statement & Financial Overview
Explore comprehensive income reports for USA Compression Partners, LP USAC, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $245.23M | $245.89M | $239.97M | $235.31M |
Cost of Revenue | $152.01M | $146.63M | $149.05M | $143.47M |
Gross Profit | $93.22M | $99.26M | $90.92M | $91.84M |
Gross Profit Ratio | $0.38 | $0.40 | $0.38 | $0.39 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $18.86M | $20.30M | $15.36M | $14.17M |
Operating Expenses | $23.83M | $24.73M | $15.36M | $14.17M |
Total Costs & Expenses | $175.84M | $171.36M | $164.29M | $157.65M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $47.37M | $48.62M | $49.36M | $48.83M |
Depreciation & Amortization | $70.39M | $68.95M | $67.24M | $65.31M |
EBITDA | $40.68M | $143.51M | $136.72M | $145.84M |
EBITDA Ratio | $0.17 | $0.58 | $0.57 | $0.62 |
Operating Income | $69.39M | $74.53M | $75.68M | $77.67M |
Operating Income Ratio | $0.28 | $0.30 | $0.32 | $0.33 |
Other Income/Expenses (Net) | -$47.34M | -$48.59M | -$55.56M | -$45.67M |
Income Before Tax | $22.05M | $25.94M | $20.12M | $31.70M |
Income Before Tax Ratio | $0.09 | $0.11 | $0.08 | $0.13 |
Income Tax Expense | $1.53M | $503000.00 | $793000.00 | $463000.00 |
Net Income | $20.51M | $25.44M | $19.33M | $31.24M |
Net Income Ratio | $0.08 | $0.10 | $0.08 | $0.13 |
EPS | $0.14 | $0.18 | $0.13 | $0.23 |
Diluted EPS | $0.14 | $0.18 | $0.13 | $0.23 |
Weighted Avg Shares Outstanding | $117.51M | $117.07M | $117.02M | $116.85M |
Weighted Avg Shares Outstanding (Diluted) | $118.25M | $118.09M | $118.26M | $117.97M |
Over the past four quarters, USA Compression Partners, LP demonstrated steady revenue growth, increasing from $235.31M in Q2 2024 to $245.23M in Q1 2025. Operating income reached $69.39M in Q1 2025, maintaining a consistent 28% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $40.68M, reflecting operational efficiency. Net income dropped to $20.51M, with EPS at $0.14. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan